The interdisciplinary team, spanning researchers from the University of Surrey, Imperial College London, IISc, and others, discovered Virulence Associated Dikinase (VadK), which evolved from pyruvate phosphate dikinase to histidine kinase. It regulates the methylcitrate cycle used by Mycobacterium tuberculosis to process energy sources from host lipids. Without ΔvadK mutants, the TB bacteria failed to grow […] The post Scientists Discover TB’s Metabolic “Control Switch” — A New Target for Tuberculosis Drugs appeared first on CBIRT .